All News #Library
Biotech
AbbVie to buy Capstan for up to $2.1B in Immunology Push
01 Jul 2025 //
PRESS RELEASE
Capstan Therapeutics Begins Phase 1 Trial of CAR-T Therapy for Au
11 Jun 2025 //
BUSINESSWIRE
Capstan Presents Preclinical Data on CPTX2309 CAR-T at ACR 2024
18 Nov 2024 //
BUSINESSWIRE
Capstan heats up ‘in vivo’ cell therapy chase with $175M fundraise
20 Mar 2024 //
BIOPHARMADIVE
Capstan Therapeutics Co-Founder Drew Weissman Awarded Nobel Prize in Physiology
02 Oct 2023 //
BUSINESSWIRE

Market Place
Sourcing Support